• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚太地区抗菌药物耐药性挑战:儿科视角

The challenge of antimicrobial resistance in the Asia-Pacific: a pediatric perspective.

作者信息

Huong Nguyen Xuan, Harrison Michelle, Kasahara Erena, Marais Ben, Putri Nina Dwi, Williams Phoebe Cm

机构信息

Phan Chau Trinh University, Vietnam.

Sydney Infectious Diseases Institute, University of Sydney, Sydney, Australia.

出版信息

Curr Opin Pediatr. 2025 Apr 1;37(2):116-123. doi: 10.1097/MOP.0000000000001437. Epub 2025 Feb 4.

DOI:10.1097/MOP.0000000000001437
PMID:39882689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11892997/
Abstract

PURPOSE OF REVIEW

The densely populated Asia Pacific region is home to 600 million children, and suffers from a significant burden of morbidity and mortality due to infections associated with antimicrobial resistance (AMR). We aimed to identify the drivers, challenges and potential opportunities to alter the burden of AMR within the region.

RECENT FINDINGS

Despite the high AMR burden borne by the Asia Pacific region, there are limited (and geographically imbalanced) published data to delineate the contemporary epidemiology of serious multidrug-resistant bacterial infections in children. Furthermore, the region is impacted by overcrowded and poorly resourced healthcare facilities, insufficient microbiological resources, and widespread community and environmental antibiotic use leading to limited efficacy for frequently prescribed antibiotics. Vaccine coverage is also inadequate and inequitable, further driving the burden of infectious disease (and antibiotic overuse) in children.

SUMMARY OF IMPLICATIONS

There are many challenges in implementing antimicrobial stewardship and infection prevention and control programs to reduce the excessive AMR disease burden in children across the Asia Pacific region, yet locally-driven strategies have successfully reduced antibiotic overuse in some settings, and should be replicated. Reducing the AMR disease burden will require improved healthcare resourcing, including better access to microbiological diagnosis, and multidisciplinary approaches to enhance infection prevention and antibiotic prescribing.

摘要

综述目的

人口密集的亚太地区有6亿儿童,因与抗菌药物耐药性(AMR)相关的感染而承受着巨大的发病和死亡负担。我们旨在确定改变该地区AMR负担的驱动因素、挑战和潜在机会。

最新发现

尽管亚太地区承受着很高的AMR负担,但用于描述儿童严重多重耐药细菌感染当代流行病学的已发表数据有限(且在地理上分布不均衡)。此外,该地区受到医疗保健设施拥挤和资源匮乏、微生物资源不足以及社区和环境中抗生素广泛使用的影响,导致常用抗生素疗效有限。疫苗接种覆盖率也不足且不公平,进一步加重了儿童传染病负担(以及抗生素过度使用)。

影响总结

在亚太地区实施抗菌药物管理以及感染预防和控制计划以减轻儿童过度的AMR疾病负担面临诸多挑战,但当地驱动的策略已在某些情况下成功减少了抗生素的过度使用,应予以推广。减轻AMR疾病负担将需要改善医疗资源,包括更好地获得微生物诊断,以及采取多学科方法加强感染预防和抗生素处方。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/91e70f0b9ed4/coped-37-116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/68606c4bf9af/coped-37-116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/3f6cdc5ac5c4/coped-37-116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/4679441131e0/coped-37-116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/91e70f0b9ed4/coped-37-116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/68606c4bf9af/coped-37-116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/3f6cdc5ac5c4/coped-37-116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/4679441131e0/coped-37-116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f0/11892997/91e70f0b9ed4/coped-37-116-g004.jpg

相似文献

1
The challenge of antimicrobial resistance in the Asia-Pacific: a pediatric perspective.亚太地区抗菌药物耐药性挑战:儿科视角
Curr Opin Pediatr. 2025 Apr 1;37(2):116-123. doi: 10.1097/MOP.0000000000001437. Epub 2025 Feb 4.
2
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.全球细菌对抗菌药物耐药性的负担 1990-2021:一项系统分析及对 2050 年的预测。
Lancet. 2024 Sep 28;404(10459):1199-1226. doi: 10.1016/S0140-6736(24)01867-1. Epub 2024 Sep 16.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
Antimicrobial resistance: a concise update.抗菌药物耐药性:简要更新
Lancet Microbe. 2025 Jan;6(1):100947. doi: 10.1016/j.lanmic.2024.07.010. Epub 2024 Sep 18.
5
Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.亚太地区复杂性尿路感染的流行病学和适当抗菌治疗的共识综述。
J Infect. 2011 Aug;63(2):114-23. doi: 10.1016/j.jinf.2011.05.015. Epub 2011 Jun 12.
6
Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review.儿科抗菌药物管理计划的实施和影响:系统范围界定审查。
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):3. doi: 10.1186/s13756-019-0659-3. eCollection 2020.
7
Prevention of antimicrobial resistance in sub-Saharan Africa: What has worked? What still needs to be done?撒哈拉以南非洲地区抗菌药物耐药性的防控:哪些措施有效?哪些措施仍有待实施?
J Infect Public Health. 2023 Apr;16(4):632-639. doi: 10.1016/j.jiph.2023.02.020. Epub 2023 Feb 21.
8
Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.欧洲移民中的抗菌药物耐药性:系统评价和荟萃分析。
Lancet Infect Dis. 2018 Jul;18(7):796-811. doi: 10.1016/S1473-3099(18)30219-6. Epub 2018 May 17.
9
Combating Antimicrobial Resistance Through a Data-Driven Approach to Optimize Antibiotic Use and Improve Patient Outcomes: Protocol for a Mixed Methods Study.通过数据驱动的方法来优化抗生素使用并改善患者结局以对抗抗菌药物耐药性:一项混合方法研究的方案。
JMIR Res Protoc. 2024 Nov 8;13:e58116. doi: 10.2196/58116.
10
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.2019 年世卫组织非洲区域细菌对抗菌药物耐药性的负担:跨国系统分析。
Lancet Glob Health. 2024 Feb;12(2):e201-e216. doi: 10.1016/S2214-109X(23)00539-9. Epub 2023 Dec 19.

本文引用的文献

1
High Rates of "Watch" and "Reserve" Class Antibiotics Used to Treat Infections in Neonates and Infants in Southeast Asia.东南亚地区用于治疗新生儿和婴儿感染的“观察”类和“储备”类抗生素使用率很高。
Pediatr Infect Dis J. 2025 Apr 1;44(4):e113-e116. doi: 10.1097/INF.0000000000004614. Epub 2025 Jan 9.
2
Antimicrobial susceptibility profiles of invasive bacterial infections among children from low- and middle-income countries in the Western Pacific Region (WPRO) - a systematic review and meta-analysis.西太平洋地区低收入和中等收入国家儿童侵袭性细菌感染的抗菌药物敏感性概况——一项系统评价和荟萃分析
Lancet Reg Health West Pac. 2024 Aug 31;51:101177. doi: 10.1016/j.lanwpc.2024.101177. eCollection 2024 Oct.
3
Beyond Early- and Late-onset Neonatal Sepsis Definitions: What are the Current Causes of Neonatal Sepsis Globally? A Systematic Review and Meta-analysis of the Evidence.
超越早发型和晚发型新生儿败血症的定义:全球新生儿败血症的当前病因有哪些?一项证据的系统评价和荟萃分析
Pediatr Infect Dis J. 2024 Sep 12;43(12):1182-90. doi: 10.1097/INF.0000000000004485.
4
Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge.气候变化、其对新发传染病的影响以及应对挑战的新技术。
Emerg Microbes Infect. 2024 Dec;13(1):2356143. doi: 10.1080/22221751.2024.2356143. Epub 2024 May 29.
5
Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics.应对新生儿和儿童抗菌药物耐药性威胁:首次由世卫组织召集的儿科抗生素药物优化实践的结果。
Lancet Child Adolesc Health. 2024 Jun;8(6):456-466. doi: 10.1016/S2352-4642(24)00048-8. Epub 2024 Apr 20.
6
The challenges of implementing infection prevention and antimicrobial stewardship programs in resource-constrained settings.在资源有限的环境中实施感染预防和抗菌药物管理计划所面临的挑战。
Antimicrob Steward Healthc Epidemiol. 2024 Apr 16;4(1):e45. doi: 10.1017/ash.2024.35. eCollection 2024.
7
Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific.东南亚及太平洋地区用于治疗新生儿和儿童严重细菌感染的经验性抗生素治疗方案中的覆盖缺口。
Lancet Reg Health Southeast Asia. 2023 Oct 31;22:100291. doi: 10.1016/j.lansea.2023.100291. eCollection 2024 Mar.
8
Implications of information heard about Dengvaxia on Filipinos' perception on vaccination.关于登革热疫苗的信息对菲律宾人接种疫苗的看法的影响。
Vaccine. 2024 Mar 7;42(7):1673-1681. doi: 10.1016/j.vaccine.2024.01.097. Epub 2024 Feb 12.
9
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance.抗微生物药物耐药性和巨大鸿沟:全球北方和全球南方在优先事项和议程上的不平等,威胁到全球对抗微生物药物耐药性的缓解。
Lancet Glob Health. 2024 Mar;12(3):e516-e521. doi: 10.1016/S2214-109X(23)00554-5. Epub 2024 Jan 23.
10
Challenges of implementing antimicrobial stewardship tools in Low to Middle Income Countries (LMICs).在低收入和中等收入国家(LMICs)实施抗菌药物管理工具面临的挑战。
Infect Prev Pract. 2023 Nov 14;5(4):100315. doi: 10.1016/j.infpip.2023.100315. eCollection 2023 Dec.